Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Premature aging in uremia.

Burton D Cohen1

  • 1Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Ave., Bronx, NY 10469, USA. burt1071@aol.com

Molecular and Cellular Biochemistry
|December 1, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Methyl group deficiency and guanidino production in uremia.

Molecular and cellular biochemistry·2003
Same author

Methyl group deficiency States.

Nephron·2002
Same journal

PER1 reduces HIF-1α nuclear accumulation and modulates vascular remodeling in hepatocellular carcinoma.

Molecular and cellular biochemistry·2026
Same journal

FCGR2A promoter variant reveals shared genetic susceptibility between IBD and stroke.

Molecular and cellular biochemistry·2026
Same journal

Chlamydia psittaci induces GSDME-mediated pyroptosis via the ROS-JNK signaling pathway.

Molecular and cellular biochemistry·2026
Same journal

Pentraxin 3 is an inflammation-related biomarker that distinguishes early-stage from mid-advanced cardiovascular-kidney-metabolic syndrome.

Molecular and cellular biochemistry·2026
Same journal

High glucose-induced mitochondrial fission promotes Müller cell activation via suppression of the Hippo pathway.

Molecular and cellular biochemistry·2026
Same journal

Correction to: Estradiol inhibits vascular endothelial cells pro-inflammatory activation induced by C-reactive protein.

Molecular and cellular biochemistry·2026
See all related articles

Guanidinosuccinic acid, a metabolite linked to kidney failure, is now understood to originate from argininosuccinic acid. This finding sheds light on uremic toxicity and premature aging in renal disease.

Area of Science:

  • Biochemistry
  • Nephrology
  • Metabolomics

Background:

  • Guanidinosuccinic acid (GSA) is an abnormal metabolite found in uremic patients, implicated in renal failure toxicity.
  • GSA contributes to bleeding issues, methyl group deficiency in dialysis patients, and atherosclerosis via hyperhomocysteinemia.
  • Despite its known associations, GSA's precise origin and role in uremic symptom severity remained unclear.

Purpose of the Study:

  • To identify the metabolic source of guanidinosuccinic acid.
  • To elucidate the biochemical pathway leading to GSA production in the context of renal disease.

Main Methods:

  • The study likely involved biochemical analysis and metabolic pathway investigation.
  • Identification of enzymatic or oxidative processes responsible for GSA formation.

Related Experiment Videos

Main Results:

  • The source of guanidinosuccinic acid has been identified as the superoxidation of argininosuccinic acid.
  • This process also yields gamma glutamic semialdehyde, an advanced glycation end product (AGE).
  • AGEs contribute to protein cross-linking, loss of function, and premature aging, particularly in renal disease and diabetes.

Conclusions:

  • The superoxidation of argininosuccinic acid is the primary source of guanidinosuccinic acid.
  • This pathway links GSA to AGE formation, explaining its contribution to uremic toxicity and accelerated aging.
  • Understanding GSA's origin provides insights into managing complications of chronic kidney disease.